Tag: Prescription Drugs
Report Details Benefits, Risks of Nivolumab for Squamous NSCLC
Benefit-risk summary shows beneficial effects for patients with metastatic SQ NSCLC
Possible Association for Bortezomib Therapy, Chalazia
Twenty-four reports of bortezomib-linked chalazia, mainly involving upper eyelid
FDA Approves Praxbind to Reverse Pradaxa’s Effect
Praxbind cleared for emergency use with Pradaxa when bleeding can't be controlled
CDC: Prescribing Practices Key to Curbing Rx Abuse
Small number of doctors write most opioid prescriptions, study finds
Budesonide May Be Beneficial in Extremely Preterm Infants
Reduced incidence of bronchopulmonary dysplasia but may be linked to increased mortality
Myopathy in Patient With Rx-Related Respiratory Symptoms
Case report describes 84-year-old male patient with myositis after nivolumab treatment
Doxycycline May Cut Bleeding With Ventricular Assist Device
ADAMTS-13 is clinical target to cut pathologic vWF degradation with LVAD support
Prescription Opioid Use Disorders Up From 2003 to 2013
Second study shows no increase in treatment for individuals with opioid use disorders
One-Third of Children See PCPs for Mental Health Conditions
More than 40 percent of children with ADHD see primary care provider only
Study of Daclizumab Yields Mixed Results in Multiple Sclerosis
Relapse rates with daclizumab were lower than with a standard therapy, but side effects were greater
